Roche completes acquisition of LumiraDx's Point of Care technology

Roche completed the acquisition of LumiraDx's Point of Care technology after receiving all regulatory clearances, integrating the multi-assay platform into its diagnostics portfolio.

“Access to diagnostic testing is critical for the delivery of healthcare worldwide and we are confident that the LumiraDx platform and technology will help us expand the availability of testing.”roche.com

• 1 source
• roche.comRoche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary careJul 29, 2024

Summarized from public sources; check the original articles before acting on it.